- Center Director
- Faculty and Staff
- Student Leadership and Ethics Board
- Join The Student Leadership & Ethics Board
- Student Leadership and Ethics Board Corner
- Ethical Implications of For Profit Impact Measurement Organizations
- Welcome Message from the Chairs
- Crafting a Career in Financial Freedom - A Montrone Seminar Series with Antonia Stroeh ’04
- SLEB Business Ethics Case Competition
- Sam Longair '18, Chair of SLEB, Reflects on his Inspiration for the Board
- Business Leaders' Focus on CSR is Misguided
- Conscious Corporate Citizenship at Work
- Defining Your Moral Purpose
- Leadership and Ethics Week
- Contact Us
- Curricular Initiatives
- The Botwinick Prize in Business Ethics
- The KPMG Peat Marwick / Stanley R. Klion Forum
- The Paul M. Montrone Seminar Series on Ethics
- Military Initiative Programming
- Diversity and Inclusion for All
- Leadership Conference
- Diversity, Equity, and Inclusion (DEI) Academic Conference
- Restoring Trust: New Realities and New Possibilities for Business Leadership
- Conscious Capitalism: How Ethical Executives Move the Needle Forward, One Business Decision at a Time
- Lucy Quist: A Global Role Model for Business Leadership
- Two Industry Pioneers Lead the Change for Clean Energy
- The Great Debate on the Ethics of Pricing in the Drug Industry
- Leading With Courage: Top Industry Trailblazers Discuss Pathways to Restoring Trust in Business
- Innovation and the Value of Privacy
- Events Calendar
- Support Us
For more than three decades, Paul Montrone has directed the development of a number of businesses in a diverse set of industries. He is currently Executive Chairman of Liberty Lane Partners and Bayberry Financial Services, both private investment groups, and Chairman and CEO Perspecta Trust LLC, a New Hampshire trust company.
Mr. Montrone was CEO of Fisher Scientific International Inc. from its initial public offering in 1991 until its merger with Thermo Electron in 2006, forming Thermo Fisher Scientific Inc. Over this period, the equity value of Fisher increased from approximately $200 million to $12 billion, and the annual return to shareholders was 26 percent compounded.
Prior to leading Fisher Scientific, Mr. Montrone was chairman and chief executive officer of Wheelabrator Technologies Inc., a leading environmental services company. Annual shareholder returns at Wheelabrator under his leadership were 22 percent compounded. Previously, Mr. Montrone was executive vice president of the Signal Companies, Inc., and its successor, AlliedSignal Inc. (now Honeywell International Inc.), as well as president of the Henley Group, Inc., and executive vice president and chief financial officer of Wheelabrator-Frye Inc.
Mr. Montrone began his career at the Pentagon, serving in the systems analysis group in the Office of Secretary of Defense Robert McNamara while a captain in the US Army. For many years, Mr. Montrone also participated in healthcare policy matters at the national level and in business policy through his activity with the Business Roundtable.
He has served on a number of corporate boards and many nonprofit institutions, especially the Metropolitan Opera, for which he was president and chief executive officer and is now president emeritus. In addition, he is on the boards of the New England Conservatory, the Boston Symphony and the Foundation for the National Institutes of Health.
Born in Scranton, Pa., in 1941, Mr. Montrone was graduated magna cum laude from the University of Scranton in 1962 and holds a PhD from Columbia University.